IL12RB2 Protein (His tag)
-
- Antigène Voir toutes IL12RB2 Protéines
- IL12RB2 (Interleukin 12 Receptor, beta 2 (IL12RB2))
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette IL12RB2 protéine est marqué à la His tag.
- Fonction
- Human IL-12 R beta 2 Protein, His Tag (MALS verified)
- Séquence
- Lys 24 - Asn 622
- Attributs du produit
- Human IL-12 R beta 2, His Tag is expressed from human 293 cells (HEK293). It contains AA Lys 24 - Asn 622 (Accession # Q99665-1).
- Pureté
- 95 %
- niveau d'endotoxine
- 1.0 EU per μg
- Classe de qualité
- MALS verified
- Top Product
- Discover our top product IL12RB2 Protéine
-
-
- Commentaires
-
This protein carries a polyhistidine tag at the C-terminus. (10xHis) The protein has a calculated MW of 70.0 kDa. The protein migrates as 66 kDa and 80-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- IL12RB2 (Interleukin 12 Receptor, beta 2 (IL12RB2))
- Autre désignation
- IL-12 R beta 2 (IL12RB2 Produits)
- Synonymes
- IL12RB2 Protein, A930027I18Rik Protein, IL-12RB2 Protein, Ifnm Protein, interleukin 12 receptor subunit beta 2 Protein, interleukin 12 receptor, beta 2 Protein, IL12RB2 Protein, Il12rb2 Protein
- Sujet
- The human IL-12 R subunit is a member of the cytokine receptor superfamily and the functional high-affinity IL-12R is composed of at least two beta-type cytokine receptor subunits, each independently exhibiting a low affinity for IL-12. IL-12RB2 is the signaling component coupling to the JAK2/STAT4 pathway. Promotes the proliferation of T-cells as well as NK cells. Induces the promotion of T-cells towards the Th1 phenotype by strongly enhancing IFN-gamma production. IL-12B2 gene acts as tumor suppressor in human acute and chronic B-cell leukemias/lymphomas, IL-12R beta 2 directly restrains multiple myeloma cell growth, and targeting of IL-12 to tumor cells holds promise as new therapeutic strategy.
- Poids moléculaire
- 70.0 kDa
- Pathways
- Signalistation JAK/STAT
-